What is Lifesci Capital’s Estimate for AVDL Q2 Earnings?
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) – Analysts at Lifesci Capital increased their Q2 2025 earnings per share estimates for Avadel Pharmaceuticals in a report issued on Thursday, June 5th. Lifesci Capital analyst M. Belghiti now forecasts that the company will post earnings of $0.05 per share for the quarter, up from their previous […]
